Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C25H23N5O2S |
Molecular Weight | 457.547 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N#C[C@H](C1=NC2=C(S1)C=CC=C2)C3=CC=NC(OCC4=CC=C(CN5CCOCC5)C=C4)=N3
InChI
InChIKey=XCPPIJCBCWUBNT-FQEVSTJZSA-N
InChI=1S/C25H23N5O2S/c26-15-20(24-28-22-3-1-2-4-23(22)33-24)21-9-10-27-25(29-21)32-17-19-7-5-18(6-8-19)16-30-11-13-31-14-12-30/h1-10,20H,11-14,16-17H2/t20-/m0/s1
Molecular Formula | C25H23N5O2S |
Molecular Weight | 457.547 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://adisinsight.springer.com/drugs/800019136
Sources: http://adisinsight.springer.com/drugs/800019136
(R)-bentamapimod is the enantiomer of Bentamapimod (AS-602801 or PGL-5), a JNK mitogen-activated protein kinase inhibitor. No data regarding stereospecificity of the pharmacological activity of bentamapimod enantiomers available.
Originator
Sources: http://adisinsight.springer.com/drugs/800019136
Curator's Comment: Originator of (R)-bentamapimod is unknown. Bentamapimod was discovered at Merck Serono.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:33:16 GMT 2023
by
admin
on
Fri Dec 15 16:33:16 GMT 2023
|
Record UNII |
0KKZ883CLJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
0KKZ883CLJ
Created by
admin on Fri Dec 15 16:33:16 GMT 2023 , Edited by admin on Fri Dec 15 16:33:16 GMT 2023
|
PRIMARY | |||
|
76969934
Created by
admin on Fri Dec 15 16:33:16 GMT 2023 , Edited by admin on Fri Dec 15 16:33:16 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |